North America Blood Purification Equipment Market By Product (Portable and Stationary), By Indication (Renal Diseases, Sepsis and Other Equipment), By End User (Dialysis Centers, Hospitals and Clinics and Other End Users), By Country, Growth Potential, Industry Analysis Report and Forecast, 2020 - 2026
Special Offering: Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
Get in-depth analysis of the COVID-19 impact on the North America Blood Purification Equipment Market
The North America Blood Purification Equipment Market would witness market growth of 4.3% CAGR during the forecast period (2020-2026). Rising cases of chronic kidney diseases (CKD) will bolster the growth of the market in the next few years.
CKDS may result in chronic renal failure that requires a constant blood purification process. As per the National Chronic Kidney Disease Fact Sheet, approximately 15% of people are expected to suffer from CKD in the U.S. alone. Around the world, an increasing number of people are suffering from kidney failure due to CKD. This situation will help the market to expand further, thereby fueling the blood purification equipment. Though, the lack of skilled professionals to manage & handle blood purification machines in underdeveloped countries may hinder the growth of the market.
Blood from the body of the patient is moved via an external machine or device for removal of impurities, toxin, or endotoxin and is come back to the body of the patient using blood collection tubing. This process is known as blood purification. Currently, blood purification methods are extensively utilized for the treatment of various diseases that are refractory to conventional therapies, like surgeries & drug administration. The blood purification is done by destroying pathogenic toxins & agents from blood with the help of various other bio-separation methods like dialysis, adsorption, or filtration. Due to these benefits as compared to the traditional techniques, blood purification is highly adopted for several autoimmune & metabolic disorder procedures.
The US market dominated the North America Stationary Market by Country in 2019, and would continue to be a dominant market till 2026. The Canada market is experiencing a CAGR of 7.2% during (2020 - 2026). Additionally, The Mexico market would witness a CAGR of 6.2% during (2020 - 2026).
The Renal Diseases market dominated the Canada Blood Purification Equipment Market by Indication in 2019, thereby, achieving a market value of $382.2 million by 2026. The Sepsis market is showcasing a CAGR of 7.3% during (2020 - 2026).
Based on Product, the market is segmented into Portable and Stationary. Based on Indication, the market is segmented into Renal Diseases, Sepsis and Other Equipments. Based on End User, the market is segmented into Dialysis Centers, Hospitals and Clinics and Other End Users. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include B. Braun Melsungen AG, Baxter International, Inc., Asahi Kasei Corporation, Nikkiso Co., Ltd., Kaneka Corporation, Cerus Corporation, Shanwaishan Medical Group, Jafron Biomedical Co., Ltd., Infomed SA, and Fresenius SE & Co. KGaA.
Scope of the Study
Market Segments Covered in the Report:
- Renal Diseases
- Other Equipments
By End User
- Dialysis Centers
- Hospitals and Clinics
- Other End Users
- Rest of North America
Key Market Players
List of Companies Profiled in the Report:
- B. Braun Melsungen AG
- Baxter International, Inc.
- Asahi Kasei Corporation
- Nikkiso Co., Ltd.
- Kaneka Corporation
- Cerus Corporation
- Shanwaishan Medical Group
- Jafron Biomedical Co., Ltd.
- Infomed SA
- Fresenius SE & Co. KGaA
Unique Offerings from KBV Research
- Exhaustive coverage
- The highest number of market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free